secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2026-08-21T20:15:14+00:00
Accession:  0001213900-26-092604
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma gets Nasdaq bid-price compliance extension to Feb 8, 2027
-----------------------------------------------------------------------

- Nasdaq granted extension to Feb 8, 2027 to regain compliance with $1.00 bid price rule.
- Must close at or above $1.00 for 10 consecutive business days before deadline.
- Failure to comply by Feb 8, 2027 triggers delisting notice; company may appeal.
- Stock remains listed on Nasdaq Capital Market under CTXR; no immediate effect.
- Company evaluating options; no assurance of regaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390026092604/0001213900-26-092604-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390026092604/ea0302856-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-092604

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer